RHEUMATOLOGY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RHEUMATOLOGY
Largest movements
- Receivables within one year -€79,016
down €79,016 (-81.6%), from €96,856 to €17,839
of which Other amounts receivable: -€74,593
- Current investments +€33,794
new in 2025: €33,794
- Tangible fixed assets -€23,964
down €23,964 (-27.7%), from €86,519 to €62,555
of which Furniture and vehicles: -€19,399
- Deferred charges and accrued income -€4,965
down €4,965 (-50.5%), from €9,825 to €4,860
- Reserves -€49,126
down €49,126 (-23.3%), from €210,550 to €161,423
- Profit (loss) carried forward -€33,697
down €33,697 (-100.0%), from €33,705 to €8
- Tax, wage and social debts +€5,949
up €5,949 (+928%), from €641 to €6,590
- Trade debts +€2,931
up €2,931, from €0 to €2,931
- Turnover +€18,780
up €18,780 (+20.7%), from €90,758 to €109,538
- Purchases and services +€16,412
up €16,412 (+43.4%), from €37,838 to €54,250
- Depreciation +€11,912
new in 2025: €11,912
- Gross operating margin +€6,711
up €6,711 (+12.6%), from €53,163 to €59,873
- Taxes +€4,820
up €4,820 (+33.2%), from €14,500 to €19,320
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €263,553 | €189,645 | -€73,908 | -28.0% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €86,519 | €62,555 | -€23,964 | -27.7% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €86,519 | €62,555 | -€23,964 | -27.7% |
| Land and buildings | 22 | €39,221 | €34,656 | -€4,565 | -11.6% |
| Furniture and vehicles | 24 | €47,298 | €27,899 | -€19,399 | -41.0% |
| Current assets | 29/58 | €177,034 | €127,090 | -€49,944 | -28.2% |
| Amounts receivable within one year | 40/41 | €96,856 | €17,839 | -€79,016 | -81.6% |
| Trade receivables | 40 | €4,423 | €0 | -€4,423 | -100% |
| Other amounts receivable | 41 | €92,433 | €17,839 | -€74,593 | -80.7% |
| Current investments | 50/53 | - | €33,794 | +€33,794 | |
| Cash at bank and in hand | 54/58 | €70,353 | €70,596 | +€243 | +0.3% |
| Deferred charges and accrued income | 490/1 | €9,825 | €4,860 | -€4,965 | -50.5% |
| Total equity and liabilities | 10/49 | €263,553 | €189,645 | -€73,908 | -28.0% |
| Equity | 10/15 | €262,912 | €180,089 | -€82,824 | -31.5% |
| Contributions | 10/11 | €18,658 | €18,658 | = | 0.0% |
| Capital | 10 | €18,658 | €18,658 | = | 0.0% |
| Issued capital | 100 | €18,658 | €18,658 | = | 0.0% |
| Reserves | 13 | €210,550 | €161,423 | -€49,126 | -23.3% |
| Distributable reserves | 133 | €210,550 | €161,423 | -€49,126 | -23.3% |
| Profit (loss) carried forward | 14 | €33,705 | €8 | -€33,697 | -100.0% |
| Amounts payable | 17/49 | €641 | €9,556 | +€8,915 | +1,391% |
| Amounts payable within one year | 42/48 | €641 | €9,521 | +€8,880 | +1,386% |
| Trade debts | 44 | €0 | €2,931 | +€2,931 | |
| Suppliers | 440/4 | €0 | €2,931 | +€2,931 | |
| Taxes, remuneration and social security | 45 | €641 | €6,590 | +€5,949 | +928% |
| Taxes | 450/3 | €641 | €6,590 | +€5,949 | +928% |
| Other amounts payable | 47/48 | €0 | €0 | = | |
| Accrued charges and deferred income | 492/3 | - | €35 | +€35 | |
| Turnover | 70 | €90,758 | €109,538 | +€18,780 | +20.7% |
| Goods, raw materials, services and sundry goods | 60/61 | €37,838 | €54,250 | +€16,412 | +43.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €11,912 | +€11,912 | |
| Other operating charges | 640/8 | €4,500 | €2,625 | -€1,874 | -41.7% |
| Non-recurring operating charges | 66A | €108 | €352 | +€244 | +225% |
| Gross operating margin | 9900 | €53,163 | €59,873 | +€6,711 | +12.6% |
| Operating profit (loss) | 9901 | €48,555 | €44,985 | -€3,570 | -7.4% |
| Financial income | 75/76B | €1 | €3,653 | +€3,653 | +730,502% |
| Recurring financial income | 75 | €1 | €3,653 | +€3,653 | +730,502% |
| Financial charges | 65/66B | €351 | €1,636 | +€1,285 | +366% |
| Recurring financial charges | 65 | €351 | €1,636 | +€1,285 | +366% |
| Profit (loss) for the period before taxes | 9903 | €48,205 | €47,002 | -€1,203 | -2.5% |
| Income taxes | 67/77 | €14,500 | €19,320 | +€4,820 | +33.2% |
| Profit (loss) for the period | 9904 | €33,705 | €27,682 | -€6,023 | -17.9% |
| Profit (loss) for the period to be appropriated | 9905 | €33,705 | €27,682 | -€6,023 | -17.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.